UK medical device testing hits record high as MHRA backs growth in brain and AI technology - GOV UK
Patients benefit from earlier access to technologies that could improve or save lives, as the MHRA approved 17 per cent more clinical investigations in 2025 compared with 2024, and launches measures to support innovation and growth.
UK patients could be among the first in the world to benefit from breakthrough medical devices, as clinical investigations reach their highest level on record in 2025.
New figures from the Medicines and Healthcare products Regulatory Agency (MHRA) show a 17 per cent rise in approved clinical investigations compared with last year, as companies increasingly choose Great Britain to test cutting-edge health technologies. At the same time, the MHRA is rolling out new measures to back innovation and remove barriers for smaller companies, including a fee waiver pilot, early market access to promising devices, and enhanced support for high-impact technologies.
For patients, this means earlier access to potentially life-changing technologies. For the NHS, it offers better tools to diagnose disease, manage long-term illness and deliver more precise treatment.
Comments